Alternative Cancer Research Fund

(dba: Prostate Cancer Research & Assistance Fund)

A Message from the President


Prostate cancer is the second most common cancer in men, and the second-leading cause of cancer death in America.  On average, 16% of men born today will be diagnosed with prostate cancer at some point in there lives; that's 1 out of every 6 men born today.  Today, over 2 million men are living with prostate cancer.  That is over 2 million reasons to support research for the treatment and prevention of such a deadly type of cancer.

The Prostate Cancer Research & Assistance Fund is driven by the challenges of providing grants and support to organizations seeking a cure for cancer and other diseases through nutritional treatment therapies.  Our efforts will continue to be directed to making informational and educational materials available to individuals with cancer, and also networking with other organizations to create an awareness that building a healthier lifestyle is essential to combating prostate cancer and chronic illness.

PCRAF is totally dependent on public support and volunteer help, we continue to look for more cost effective ways to provide the vital educational materials about nutrition and alternative treatments for cancer and other degenerative diseases.  We continue to focus on acquiring and placing much needed medical equipment and supplies in the clinics and hospitals that provide cancer treatment programs.  As a result, these clinics are able to provide much more cost effective programs for cancer patients and their families.

We welcome you to be a part of our effort to rid the world of prostate cancer and other chronic illnesses due to cancer.  Our programs focus on supporting research into non-invasive, non-toxic methods of treating cancer.  We will continue to support the fight against cancer and other life-threatening diseases.  There are alternative therapies; there is a way to build a healthier lifestyle!

Thank you for continued support,

"Awareness builds a healthier lifestyle."